| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Funtleyder Leslie D. | Chief Financial Officer, Director | C/O APPLIED THERAPEUTICS, INC., 545 FIFTH AVENUE, SUITE 1400, NEW YORK | /s/ Leslie D. Funtleyder | 2025-07-03 | 0001775394 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | APLT | Common Stock | Award | $0 | +150K | +23.54% | $0.00 | 787K | Jun 9, 2025 | Direct | F1, F2 |
| transaction | APLT | Common Stock | Award | $0 | +150K | +19.06% | $0.00 | 937K | Jul 1, 2025 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following April 1, 2025, subject to the Reporting Person continuing to provide services through each such date. |
| F2 | The total holdings have been adjusted to correct an administrative error in prior Form 4s that resulted in the overstatement of the total holdings. |
| F3 | Consists of compensatory RSUs granted under the Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following July 1, 2025, subject to the Reporting Person continuing to provide services through each such date. |
Interim Chief Executive Officer and Chief Financial Officer